Retrospective study in a NSCLC M+ p - Ca_Pulmon

Study identifier:NIS-OES-XXX-2012/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Observational retrospective study to describe the management of advanced or metastatic EGFR (Epidermal Growth Factor Receptor) mutated non-small cell lung cancer patients in Spain

Medical condition

EGFR mutated non-small cell lung cancer patients

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

187

Study type

Observational

Age

18 Years - 99 Years

Date

Study Start Date: 01 Mar 2013
Primary Completion Date: 01 Oct 2013
Study Completion Date: 01 Oct 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria